Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Target ID: TTDS00461

Target Information
Name26S proteasome    
Type of targetSuccessful target    
DiseaseMultiple myeloma    [1]
Drug(s)BortezomibApprovedMultiple myeloma[1]
BortezomibPhase IIIFollicular NHL and MCL[1][2][3]
BioChemical ClassProtease    
Target ValidationClick to Find Target Validation Information.    
InhibitorBortezomib[1][2][3]
Bortezomib[1]
Cross References 3D Structure
Related Literature
On-Line Medical Dictionary
Ref 1Bortezomib: a novel chemotherapeutic agent for hematologic malignancies. Am J Health Syst Pharm. 2008 Jul 1;65(13):1221-31. To Reference
Ref 2Takeda. Product Development Pipeline. July 31 2009. To Reference
Ref 3Phase II study of the proteasome inhibitor bortezomib (PS-341, Velcade((R))) in chemotherapy-na?¡¥ve patients with advanced stage non-small cell lung cancer (NSCLC). Lung Cancer. 2009 Jun 11. [Epub ahead of print] To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543